Article info
PDFCorrespondence
Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic—World Scleroderma Foundation preliminary advice for patient management’
- Correspondence to Miss Kseniia Vasileva, Sechenov University, Moscow, Russian Federation; kseniya07101988{at}mail.ru; Madam Elena Snarskaya, I.M.Sechenov First Moscow State Medical University, Moscow, Russia; snarskaya-dok{at}mail.ru
Citation
Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic—World Scleroderma Foundation preliminary advice for patient management’
Publication history
- Received November 13, 2020
- Accepted November 17, 2020
- First published January 6, 2021.
Online issue publication
May 25, 2023
Article Versions
- Previous version (25 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage